Cargando…

Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat

Histone deacetylase inhibitors (HDACi) are the most widely studied HIV latency-reversing agents (LRAs). The HDACi suberoylanilide hydroxamic acid (vorinostat [VOR]) has been employed in several clinical HIV latency reversal studies, as well as in vitro models of HIV latency, and has been shown to ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maxwell, Jill W., Falcinelli, Shane D., Nefedov, Alexey, Dorfmeier, Corin, Wu, Guoxin, Dewey, Morgan, Webber, Andrea L., Archin, Nancie M., Margolis, David M., Hazuda, Daria J., Barnard, Richard J. O., Howell, Bonnie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Cellular Response to Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307144/ https://www.ncbi.nlm.nih.gov/pubmed/32295913 http://dx.doi.org/10.1128/JVI.00351-20

Ejemplares similares

New Frontiers in Measuring and Characterizing the HIV Reservoir
por: Falcinelli, Shane D., et al.
Publicado: (2019)

In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection
por: Tsai, Perry, et al.
Publicado: (2016)

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection
por: Gay, Cynthia L., et al.
Publicado: (2020)

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
por: Archin, NM, et al.
Publicado: (2012)

Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells
por: Sung, Julia A., et al.
Publicado: (2017)

Crotonylation sensitizes IAPi-induced disruption of latent HIV by enhancing p100 cleavage into p52
por: Li, Dajiang, et al.
Publicado: (2021)

Improved Detection of HIV Gag p24 Protein Using a Combined Immunoprecipitation and Digital ELISA Method
por: Wu, Guoxin, et al.
Publicado: (2021)

Response to peer commentaries
por: Mehlman, Maxwell J., et al.
Publicado: (2015)

Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
por: Hrzenjak, Andelko, et al.
Publicado: (2010)

Effect of histone deacetylase inhibitor (vorinostat) on new-onset diabetes induced by tacrolimus
por: Bakhdar, Fatmah A., et al.
Publicado: (2022)

Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells
por: Phillip, Cornel J, et al.
Publicado: (2012)

Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
por: Saelen, Marie Grøn, et al.
Publicado: (2012)

Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells
por: Eto, Shotaro, et al.
Publicado: (2019)

Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration
por: Wolf, Ines M. L., et al.
Publicado: (2014)

Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor
por: Goehringer, Nils, et al.
Publicado: (2021)

Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015)

HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model
por: Honeycutt, Jenna B, et al.
Publicado: (2013)

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
por: Munster, P N, et al.
Publicado: (2009)

Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma
por: O'Connor, O A
Publicado: (2006)

Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020)

Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension
por: Applegate, Tanya J., et al.
Publicado: (2021)

Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor
por: Richon, V M
Publicado: (2006)

The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway
por: Sarfstein, Rive, et al.
Publicado: (2011)

The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
por: Hutt, Darren M., et al.
Publicado: (2014)

Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis
por: Laengle, Johannes, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest
por: Yang, Yang, et al.
Publicado: (2021)

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
por: LaBonte, Melissa J, et al.
Publicado: (2009)

Purchasing Research from or for the NHS?
por: Smyth, J F
Publicado: (1994)

Response to Leptin-deficient mice are not hypothermic, they are anapyrexic
por: Kaiyala, Karl J., et al.
Publicado: (2017)

Response: Association of Thigh Muscle Mass with Insulin Resistance and Incident Type 2 Diabetes Mellitus in Japanese Americans (Diabetes Metab J 2018;42:488–95)
por: Han, Seung Jin, et al.
Publicado: (2019)

Response to the letter by Esteves et al.
por: Send, T. S., et al.
Publicado: (2018)

In response to Ballantyne and Schaefer’s ‘Consent and the ethical duty to participate in health data research’
por: Hepgul, Nilay, et al.
Publicado: (2019)

Antimicrobial Management of Disseminated Strongyloidiasis in a COVID-19 Patient
por: Lier, Audun J., et al.
Publicado: (2020)

Trust, vulnerable populations, and genetic data sharing
por: Arias, Jalayne J., et al.
Publicado: (2015)

Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
por: van Leeuwen, Jolijn R., et al.
Publicado: (2022)

Response to Carter et al.
por: Eklund, Martin, et al.
Publicado: (2020)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

Response to M Krkošek, C W Revie, B Finstad and C D Todd's comment on Jackson et al. ‘Impact of Lepeophtheirus salmonis infestations on migrating Atlantic salmon, Salmo salar L., smolts at eight locations in Ireland with an analysis of lice-induced marine mortality’
por: Jackson, D, et al.
Publicado: (2014)

Fundamental problems with the cooperative breeding hypothesis. A reply to Burkart & van Schaik
por: Thornton, A., et al.
Publicado: (2016)

Letter to the Editor Response Regarding “Research Equity in Otolaryngology–Head and Neck Surgery”
por: Patterson, Rolvix Harlan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_55cu9e7ifecttqblpqotu2dgfe